Publications by authors named "P La Riviere"

Optical aberrations hinder fluorescence microscopy of thick samples, reducing image signal, contrast, and resolution. Here we introduce a deep learning-based strategy for aberration compensation, improving image quality without slowing image acquisition, applying additional dose, or introducing more optics. Our method (i) introduces synthetic aberrations to images acquired on the shallow side of image stacks, making them resemble those acquired deeper into the volume and (ii) trains neural networks to reverse the effect of these aberrations.

View Article and Find Full Text PDF

The editorial introduces the special issue on photon counting detectors and applications.

View Article and Find Full Text PDF

Purpose: High soft-tissue contrast imaging is essential for effective radiotherapy treatment. This could potentially be realized using both megavoltage and kilovoltage x-ray sources available on some therapy treatment systems to perform "MV-kV" dual-energy (DE) computed tomography (CT). However, noisy megavoltage images obtained with existing energy-integrating detectors (EIDs) are a limiting factor for clinical translation.

View Article and Find Full Text PDF
Article Synopsis
  • The study assesses real-world outcomes and failure patterns in patients with muscle-invasive bladder cancer (MIBC) who underwent trimodality therapy (TMT) between 2000 and 2018, utilizing data from the Veterans Affairs database.
  • Results indicate that out of 347 patients treated with TMT, 44% had no recurrence, while 37% experienced metastatic recurrence (MR) and 34% had local recurrence (LR), highlighting significant rates of recurrence within the patient population.
  • The findings suggest that TMT is generally effective in treating MIBC, but the high recurrence rates, particularly with lymph node positive disease and pre-treatment hydronephrosis, stress the importance of ongoing patient monitoring and the exploration of better treatment strategies
View Article and Find Full Text PDF

rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo are WHO-prequalified vaccination regimens against Ebola virus disease (EVD). Challenges associated with measuring long-term clinical protection warrant the evaluation of immune response kinetics after vaccination.

View Article and Find Full Text PDF